HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Norfloxacin

Subscribe to New Research on Norfloxacin

A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.

Also Known As:

AM-0715; AM-715; MK-0366; MK-366; MK0366; MK366; Merck Brand of Norfloxacin; Noroxin; AM 0715; AM 715; AM0715; MK 0366; MK 366; Norfloxacin Merck Brand; 3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-

Networked: 689 relevant articles (122 outcomes, 147 trials/studies) for this Drug, Comments

Relationship Network

Drug Context: Research Results

Experts

1.	Zapater, Pedro: 4 articles (11/2009 - 09/2006)
2.	Such, José: 4 articles (11/2009 - 09/2006)
3.	Pérez-Mateo, Miguel: 4 articles (11/2009 - 09/2006)
4.	Pascual, Sonia: 4 articles (11/2009 - 09/2006)
5.	Muñoz, Carlos: 4 articles (11/2009 - 09/2006)
6.	Francés, Rubén: 4 articles (11/2009 - 09/2006)
7.	Navasa, Miquel: 4 articles (04/2009 - 01/2002)
8.	Fernández, Javier: 4 articles (09/2007 - 01/2002)
9.	Caño, Rocío: 3 articles (11/2009 - 07/2007)
10.	González-Navajas, José M: 3 articles (03/2008 - 09/2006)

Related Diseases

1.	Infection 01/01/1988 - "In 12 recent clinical studies, norfloxacin given in various dosage regimens was shown to be highly effective in treating 1,588 gonococcal infections in 1,486 patients. " 01/01/1986 - "Norfloxacin has a well proven efficacy in UTI but remains to be proven in enteric infections." 06/01/1983 - "Clinical results were excellent in both groups; norfloxacin was effective in infections due to Ps. " 11/01/1986 - "[Epidemiologic and therapeutic study on gonococcal infections--clinical efficacy of norfloxacin]" 01/01/1986 - "Preliminary data from ongoing trials have also shown that norfloxacin is effective in the prophylaxis of traveller's diarrhoea and infections in the granulocytopenic patient. " Order ALL the reference details at left...
2.	Urinary Tract Infections (Urinary Tract Infection) 01/01/1990 - "Norfloxacin was also highly effective in the treatment of multiply resistant, nosocomial urinary tract infections (UTIs), in which Pseudomonas aeruginosa and E. " 04/01/1998 - "Norfloxacin 400 mg twice-a-day has proven to be effective and safe in the treatment of uncomplicated urinary tract infections (UTI). " 06/01/1992 - "CONCLUSIONS.-Three days of norfloxacin therapy is more effective than single-dose therapy for women with acute, uncomplicated urinary tract infection. " 01/01/1988 - "The therapeutic efficacy and safety of norfloxacin 400 mg twice daily for 3 or 7 days was compared in a double-blind randomized multiclinic study including 485 female general practice patients with uncomplicated symptomatic lower urinary tract infections. " 04/01/1998 - "In this study, norfloxacin 800 mg once-a-day was as effective and safe as norfloxacin 400 mg twice-a-day in the treatment of uncomplicated urinary tract infections in women." Order ALL the reference details at left...
3.	Bacterial Infections (Bacterial Infection) 06/15/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the eyelids or conjunctiva, or both. " 01/01/1992 - "Norfloxacin appears to be an effective and relatively safe agent for the treatment of bacterial infections of the lids and/or conjunctiva. " 05/01/1992 - "The aim of the study has been to assess if intermittent treatment with norfloxacin could be able to maintain selective intestinal decontamination in cirrhotic patients in order to prevent bacterial infections. " 04/01/2009 - "However, treatment should be recommended with caution in individuals with poor liver function who do not receive norfloxacin prophylaxis for SBP, since it increases the risk of bacterial infections." 08/01/1999 - "Three bacterial infections in patients from Group I, 3 from Group II patients receiving norfloxacin and 16 from Group II patients not receiving norfloxacin were recorded (p<0.05). " Order ALL the reference details at left...
4.	Diarrhea 06/26/1987 - "These studies indicate that norfloxacin is safe and effective therapy for bacterial diarrhea." 10/01/1993 - "Norfloxacin proved to be safe and effective in therapy for traveler's diarrhea." 12/01/1998 - "On this trek she had developed diarrhea which had been cured with norfloxacin 400 mg two times per day for 3 days. " 10/01/1993 - "Clinical efficacy of norfloxacin for treatment of traveler's diarrhea in 106 Finnish tourists vacationing in Morocco was evaluated during two different seasons. " 10/01/1993 - "Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons." Order ALL the reference details at left...
5.	Peritonitis 03/01/1997 - "Continuous long-term selective intestinal decontamination with norfloxacin is effective in preventing the first spontaneous bacterial peritonitis in cirrhotic patients at high risk. " 06/01/2002 - "Norfloxacin was more effective in the prevention of peritonitis recurrence due to Enterobacteriaceae (0% vs 22%, P = .01). " 01/01/1997 - "The study was performed to compare the spontaneous bacterial peritonitis occurring in patients with and without prophylactic norfloxacin. " 10/01/1990 - "Eighty cirrhotic patients who had recovered from an episode of spontaneous bacterial peritonitis were included in a multicenter, double-blind trial aimed at comparing long-term norfloxacin administration (400 mg/day; 40 patients) vs. placebo (40 patients) in the prevention of spontaneous bacterial peritonitis recurrence. " 04/01/2009 - "Importantly, the incidence of spontaneous bacterial peritonitis (SBP) in patients who were not receiving norfloxacin prophylaxis (n=83) was significantly higher in the treated group than in controls (log-rank=0.01). " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Ciprofloxacin (Cipro)
2.	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
3.	Ofloxacin (Levofloxacin)
4.	lomefloxacin (Maxaquin)
5.	Pefloxacin
6.	Quinolones
7.	Ceftriaxone (Ceftriaxon)
8.	Fluoroquinolones
9.	Cinoxacin (Cinobac)
10.	Ampicillin (Omnipen)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Oral Administration
3.	Antibiotic Prophylaxis
4.	Stents
5.	Bone Marrow Transplantation (Transplantation, Bone Marrow)

blog comments powered by Disqus

TREATMENT OPTIONS
for Infection,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 14555 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>